MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, DARE has $30,748,574 in assets. $27,890,671 in debts. $23,075,261 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
117.85%
Cash Ratio
108.76%
Debt to Asset Ratio
90.71%
Assets Breakdown
    • Cash and cash equivalents
    • Finance lease right-of-use asset
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred grant funding
    • Others

Unit: Dollar
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
23,075,261 5,035,006
Other receivables
369,157 188,116
Prepaid expenses
1,506,603 1,379,295
Other current assets
53,159 -
Total current assets
25,004,180 6,602,417
Property and equipment, net
1,657,255 1,651,656
Operating lease right-of-use assets
824,693 955,651
Finance lease right-of-use asset
2,244,073 2,699,899
Other non-current assets
1,018,373 1,069,902
Total assets
30,748,574 12,979,525
Accounts payable
1,844,862 1,762,600
Accrued expenses
2,324,931 2,523,603
Deferred grant funding
14,557,265 12,326,879
Current portion of liability related to the sale of future royalties
10,542 187,966
Current portion of lease liabilities, operating
609,224 588,478
Current portion of lease liability, finance
1,869,570 1,831,617
Total current liabilities
21,216,394 19,221,143
Deferred revenue, non-current
1,000,000 1,000,000
Liability related to the sale of future royalties, net
5,220,525 4,879,024
Lease liabilities long-term, operating
288,566 448,206
Lease liability long-term, finance
165,186 164,412
Total liabilities
27,890,671 25,712,785
Common stock, 0.0001 par value 240,000,000 shares authorized 13,929,502 and 8,700,386 shares issued and outstanding at september30, 2025 and december31, 2024, respectively
1,393 903
Additional paid-in capital
190,499,662 171,353,083
Accumulated other comprehensive loss
-395,966 -402,826
Accumulated deficit
-187,247,186 -183,684,420
Total stockholders' equity (deficit)
2,857,903 -12,733,260
Total liabilities and stockholders' equity (deficit)
30,748,574 12,979,525
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Other current assets$53,159 Prepaid expenses$1,506,603 Other receivables$369,157 Cash and cashequivalents$23,075,261 Other non-currentassets$1,018,373 Finance leaseright-of-use asset$2,244,073 Operating leaseright-of-use assets$824,693 Property and equipment,net$1,657,255 Total current assets$25,004,180 Total assets$30,748,574 Total liabilities andstockholders' equity...$30,748,574 Total stockholders'equity (deficit)$2,857,903 Total liabilities$27,890,671 Accumulated deficit-$187,247,186 Accumulated othercomprehensive loss-$395,966 Additional paid-in capital$190,499,662 Lease liabilitylong-term, finance$165,186 Lease liabilitieslong-term, operating$288,566 Liability related to thesale of future...$5,220,525 Deferred revenue,non-current$1,000,000 Total currentliabilities$21,216,394 Common stock, 0.0001par value...$1,393 Current portion of leaseliability, finance$1,869,570 Current portion of leaseliabilities, operating$609,224 Current portion ofliability related to the...$10,542 Deferred grant funding$14,557,265 Accrued expenses$2,324,931 Accounts payable$1,844,862

Dare Bioscience, Inc. (DARE)

Dare Bioscience, Inc. (DARE)